IFNGR1 and glioblastoma: Given that the loss of IFNγR1 signaling has been implicated as major mechanism of glioblastoma-intrinsic resistance to CAR T cells, successful immunotherapy requires maintenance of the physical mechanics of cytotoxicity and an adequate synapse between tumor and CAR T cells [88].